Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US9370496B2 · kind B2 · utility
19Cited by
44References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 9, 2013 |
| Grant date | Jun 21, 2016 |
| Priority date | — |
| Expiry date | Apr 9, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating Leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.